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Abstract
Background: Trials often struggle to achieve their target sample size with only half doing so. Some researchers
have turned to Electronic Health Records (EHRs), seeking a more efficient way of recruitment. The Scottish Health
Research Register (SHARE) obtained patients’ consent for their EHRs to be used as a searching base from which
researchers can find potential participants. However, due to the fact that EHR data is not complete, sufficient or
accurate, a database search strategy may not generate the best case-finding result. The current study aims to
evaluate the performance of a case-based reasoning method in identifying participants for population-based clinical
studies recruiting through SHARE, and assess the difference between its resultant cohort and the original one
deriving from searching EHRs.
Methods: A case-based reasoning framework was applied to 119 participants in nine projects using two-fold cross-
validation, with records from a further 86,292 individuals used for testing. A prediction score for study participation
was derived from the diagnosis, procedure, pharmaceutical prescription, and laboratory test results attributes of
each participant. Evaluation was conducted by calculating Area Under the ROC Curve and information retrieval
metrics for the ranking list of the test set by prediction score. We compared the most likely participants as
identified by searching a database to those ranked highest by our model.
Results: The average ROCAUC for nine projects was 81% indicating strong predictive ability for these data.
However, the derived ranking lists showed lower predictive performance, with only 21% of the persons ranked
within top 50 positions being the same as identified by searching databases.
Conclusions: Case-based reasoning is may be more effective than a database search strategy for participant
identification for clinical studies using population EHRs. The lower performance of ranking lists derived from case-
based reasoning means that patients identified as highly suitable for study participation may still not be recruited.
This suggests that further study is needed into improvements in the collection and curation of population EHRs,
such as use of free text data to aid reliable identification of people more likely to be recruited to clinical trials.
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Background
Paradoxically, Randomised Controlled Trials (RCTs) often
fail because they fail to recruit sufficient study subjects,
even when many potential study subjects would agree to
participate [1]. They are often not asked to participate
because of inefficiencies in recruitment processes. The re-
cent Cochrane review conducted by Treweek et al. of 72
different recruitment strategies identified only three effect-
ive interventions with high certainty and another four with
moderate certainty [2]. Electronic Health Records have re-
cently become increasingly important sources for identify-
ing trial participants [3–6].
A potential application of EHR data analysis is to iden-
tify prospective participants for forthcoming RCTs,
thereby improving the recruitment and selection
process. A 2015 study showed that careful analysis of
EHR data could reliably identify individuals eligible to
participate in clinical trials [7]. For each of 13 diverse
clinical trials - each conducted at Columbia University -
diagnostic, pharmacy, laboratory results and case notes
from participants were used to derive a profile of an
idealised target patient. Candidate participants were then
matched in terms of conformity to this profile, based on
their EHR data. The reported Area Under the ROC
curve of 95% demonstrates the utility of both EHRs and
the analytical approach taken. The problem remains of
translating this approach to a population-based and
multi-centre clinical study setting.
The Scottish Health Research Register (SHARE) [8] al-
lows searching of linked EHR data for people using the
Scottish National Health Service (NHS) who have opted
in to allow access to their data for this purpose [9].
There are similar developments in other countries [10].
SHARE registrants are therefore population based, and
can, in principle, be assessed as potential participants in
clinical studies and other ethically approved, methodo-
logically rigorous research. Scotland has 14 regional
health boards delivering services to its 5.6M citizens,
and RCTs are conducted within and amongst any com-
bination of boards. Figure 1 shows the workflow for the
use of SHARE in recruitment of participants to forth-
coming studies. Participant selection with SHARE is
currently performed by searching the corresponding
fields in the EHRs according to the elements contained
in the study inclusion/exclusion criteria provided by the
study researcher to the staff in the Health Informatics
Centre: University of Dundee (HIC) [11]. This approach
may fail to identify suitable participants due to incom-
plete and/or insufficient EHR data.
In this paper we investigate whether case-based rea-
soning, i.e. the use or adaptation of existing solutions
may be applied to new problem instances [7], can
Fig. 1 Work flow for recruiting participants to clinical studies through SHARE [11].
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generate a good predictive performance in participant
identification for multi-centre and population-based
studies in the Scottish EHR setting.
Methods
The objective of this study is to: (1) evaluate the predict-
ive performance of case-based reasoning (CBR) in stud-
ies conducted in a multi-centre and population-based
manner using a range of different EHRs, (2) assess the
consistency of participant prediction results between
CBR and the database search strategy.
The current study included nine completed projects
from SHARE for analysis. The process of inclusion is de-
scribed in Fig. 2. These projects had completed recruit-
ment before the end of 2017. They recruited participants
across the health boards in Eastern Scotland. Finally,
three projects without recruitment data recorded were
also excluded.
The additional table (see additional file 1) summarizes
the inclusion/exclusion criteria, number of participants
required by the nine projects and the number of poten-
tial participants identified by searching database, the
number of persons finally recruited in each project and
how many of them were identified in the database. The
projects involved from 2 to 28 participants, with no par-
ticipant being recruited into more than one project. A
total of 119 people were enrolled in these nine projects.
We chose the individual final recruitment status re-
corded in SHARE as our gold standard to train and
evaluate our algorithm since (i) we can compare our
evaluation results with those from the original study
because Miotto & Weng also used the final enrolment
results as gold standard, and (ii) it is almost impossible
to confirm the real eligibility of each person and use
them as gold standard since this is a retrospective study.
The Community Health Index (CHI) is a population
register, which is used in Scotland for healthcare purposes
[12]. A CHI number uniquely identifies a person on the
index. The data from selected projects were de-identified
by removing personal data such as names, addresses and
date of birth, and linked through CHI number for each
participant. Recruitment data were extracted and compiled
by HIC, composed of persons identified and recruited for
each of the nine projects. Clinical data – diagnosis, proced-
ure, prescription and laboratory test were requested for all
119 participants and all other registrants of SHARE in the
NHS Scotland Fife and Tayside areas (n = 90,456). Follow-
ing assessment of the time frames of the projects to be ana-
lysed and the availability and completeness of the clinical
data needed, the requested clinical data range from 2010
through 2017. Diagnoses were recorded using the Inter-
national Classification of Diseases revision 10 (ICD-10).
Procedures were recorded using the Office of Population
Censuses and Surveys, Classification of Surgical Operations
and Procedures version 4 (OPCS-4). Prescriptions were re-
corded using unique identifiers mapped to British National
Formulary (BNF) codes [13] to identify the drug pre-
scribed. Prescription data also included the quantities of
each prescription dispensed. Finally, laboratory test data
consisted of test names, read codes allocated to the specific
Fig. 2 Flow diagram for the selection of projects for analysis
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test, and test results. Data were accessed and analysed
through the data safe haven provided by HIC [14, 15].
Diagnoses and procedures were presented in entity-
attribute-value (EAV) model [16, 17] in wide form in
which one record of a certain person contains several
diagnoses and procedures, the numbers of which vary
from person to person. For example, patient A’s first
record has diagnoses of pneumonia, diabetes, hyperten-
sion. These data were first transformed into a long EAV
form with one record comprising one diagnosis or pro-
cedure alone. Prescription data were mapped to format-
ted BNF codes and the records with unidentifiable maps
were excluded [18]. To ensure that each person included
for analysis had some meaningful clinical data recorded,
individuals with no diagnosis or procedure or prescrip-
tion or lab test were excluded, as were those subjects
having test results but incomplete test description. As a
result, 119 participants having at least one record in
diagnosis, procedure, prescription and lab test were in-
cluded for further analysis. Eight six thousand two hun-
dred ninety-two other registrants were included for use in
test datasets for model assessment and validation pur-
poses, being the subset of the 90,456 SHARE subjects that
met the same inclusion criteria as the 119 participants.
Each project was analysed separately by two-fold cross-
validation. For both folds, half of the 119 participants were
used to train a predictive model. The remaining half were
combined with (i) 30,000 SHARE registrants chosen ran-
domly from the 86,292 available and (ii) all subjects identi-
fied though inclusion/exclusion database queries for the
project but not selected as one of our 119 cases (people
enrolled in studies). This test dataset was used to assess
prediction errors for subjects not used to derive the
model. Following the methodology of Miotto and Weng,
2015 [7], a target profile was derived from central tenden-
cies of the occurrences of the codes from diagnosis, pro-
cedure, prescription and laboratory test. The featured
codes were determined according to their frequencies
among that project’s participants, with each entity (being
either a diagnosis, a procedure, a prescription or a labora-
tory test) requiring a minimum of 10 codes shared by at
least 80% of the participants. If more than 10 codes were
retrieved in one entity, all the codes exceeding 80%
threshold were included. If the data were sparse, with no
code reaching 80%, all the codes were retained. After the
target profile had been produced, for every individual a
similarity score was produced for each of the four entities
respectively by being compared against the target using
cosine similarity, which uses orientation of entities when
plotted in multi-dimensional space to assess similarity ra-
ther than magnitude of difference apart in the same space
[19]. Thus, each person was represented by four similarity
scores ranging from 0 to 1. The training set was used to
train a linear regression model to get four optimal weights
for each entity, which were then applied to each individual
in the test set to obtain a final score which was then scaled
to fall between 0 and 1.
For each project, the area under the Reciever-Observer
Characteristic curve (ROCAUC) was calculated for
either testing fold respectively, and average scores were
obtained for projects individually and for the nine pro-
jects as a whole. ROCAUC measures the overall per-
formance of a binary classifier [20]. It estimates the
probability of obtaining a higher score for a participant
than for a non-participant. The higher the ROCAUC,
the better the classifier. For this study ROCAUC are
interpreted using a standard quality scheme as follows:
90–100 = excellent; 80–90 = good; 70–80 = fair; 60–70 =
poor; 50–60 = fail [21]. The confidence interval (CI) for
ROCAUC was generated through 2000 bootstrap repli-
cates [22]. Prediction results were also combined to
identify the cut-off maximizing the performance metric
that sums up sensitivity and specificity.
A ranking list was generated for each test set, with in-
dividual final scores decreasing for assessment with re-
gard to their ability to find the person recruited using
metrics such as precision of predicting the 5 top items
(P5) [23], precision of predicting the 10 top items (P10)
[23], the mean average precision (MAP) [24] and mean
reciprocal rank (MRR) [25]. Average precision combines
the precisions obtained every time a relevant result is re-
trieved, thereby assessing the quality of the whole list.
Reciprocal rank is the reciprocal of the rank of the first
targeted person retrieved, reflecting the utility of the list
to meet the need of the list users when identifying suit-
able participants. The best possible result for the list
with participants ranked at the top (Upper) and the
worst result - a random list (Lower) were also obtained
as references. The metrics were averaged across all 18 (i.e.
2 fold for each of 9 projects) ranking lists respectively.
We additionally examined how many of the persons
identified by database queries were among the top 50 of
the ranking list in proportion.
Results
The ROCAUC for each project and each fold are shown
in Table 1. The mean ROCAUC for prediction score
was 0.815 over nine projects. One project had unaccept-
ably low ROCAUC for prediction score (0.337) being
worse than a random guess, with another project giving
poor discriminatory performance (ROCAUC 0.619) The
remaining eight projects were either good or excellent in
terms of ROCAUC.
A threshold of 0.44 gives the maximum performance
metric for these data. A plot of performance against dif-
ferent prediction score cut-offs is shown in Fig. 3; the
scaled sum of sensitivity and specificity was calculated
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for precision score thresholds from zero to 100%, with
the optimal cut-off for these data occurring at 44%.
Ranking list results are shown in Table 2. Overall, the
ranking list failed to present the relevant participants at
neither the top 5 positions nor the top 10. Performance
improved when trying to find participants from the top
of the list of roughly 30,000 patients compared to a ran-
dom list, but was still far from optimal.
On average, 21% of the persons ranked within the top
50 positions on the ranking list were the same as identi-
fied by searching databases. The proportions of those
both identified listed in the top 50 of the list for each
project are presented in Table 3.
Discussion
Our ROCAUC results indicate that we can reliably and
retrospectively predict the recruitment status for seven
of the nine projects analysed, with IMPOCT and Immu-
noStat being harder to predict in terms of participation.
We speculate that, for IMPOCT study, the poor result
was caused by only two participants being recruited, so
that only one person was used to derive the target
profile of participants. Considering the relatively loose
inclusion/exclusion criteria for ImmunoStat, this less
satisfactory performance may result from an inherent
inability of capturing a representative target due to scat-
tered participant characteristics. For the higher-quality
projects, ROCAUC is either good (i.e. above 80%) or
excellent (i.e. above 90%), providing strong support for
our central claim that careful analysis of EHR data can
reliably discriminate participation status for projects of
sufficiently high quality.
Evaluation of the resultant ranking lists showed poor
performance in retrieving the real participants at the
top. None of the ranking lists identified participants at
either the first five individuals retrieved or the first 10.
The ranking performance was the worst for IMPOCT
project, consistent with the AUC result. Performance
Table 1 The Area Under the ROC Curve for recruitment prediction test for each project. For each project the ROCAUC and 95%
confidence intervals are given for the first and second cross validation datasets, followed by the average
Project Acronym Fold 1 (CI) Fold 2 (CI) Average (CI)
ALPHA 0.947 (0.897–0.984) 0.855 (0.777–0.928) 0.901 (0.837–0.956)
ALLAY 0.928 (0.903–0.955) 0.854 (0.768–0.941) 0.891 (0.836–0.948)
METFORMIN 0.977 (0.970–0.989) 0.980 (0.970–0.983) 0.979 (0.970–0.986)
REFORM 0.946 (0.896–0.980) 0.957 (0.920–0.987) 0.952 (0.908–0.984)
IMPOCT 0.397 (NA) 0.276 (NA) 0.337 (NA)
TARDIS 0.897 (0.844–0.946) 0.887 (0.852–0.919) 0.892 (0.848–0.933)
4P 0.952 (0.909–0.993) 0.744 (0.447–0.978) 0.848 (0.678–0.986)
HF 0.907 (0.851–0.957) 0.927 (0.870–0.974) 0.917 (0.861–0.966)
ImmunoStat 0.632 (0.503–0.763) 0.605 (0.443–0.756) 0.619 (0.473–0.760)
NA: insufficient data to calculate an accurate CI
Fig. 3 Scaled sensitivity plus specificity against prediction score cut-offs
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improves slightly when identifying persons recruited and
selecting the first candidate for participation, but is still
unsatisfactory in terms of matching predicted to actual
participants.
The assessment of the consistency of patients identi-
fied by case-based reasoning and database query shows
there is significant discrepancy among the potential par-
ticipants detected by the two methods. However, it is
unknown whether the most likely participants identified
from our ranking lists would have been recruited or not
due to the retrospective nature of our study, so there is
an inherent lack of discriminative ability involved. Also
the list of eligible participants derived from searching
the database is definitely not exhaustive. As shown in
the project summary table (see additional file 1), a few of
the participants were not among the persons identified
in database at all. Therefore, the non-participants picked
up by the ranking list who were not identified before
might have been actual participants.
Our study has the following strengths: we have used
recruitment data from real clinical studies involving
multiple health boards and multiple data sources; the
EHR data is population based and hence is not flawed by
selection or geographic bias; we have used an analogue
of an existing proven methodology augmented with
cross validation and relative ranking analysis; we have
compared the potential participants between two detect-
ing strategies.
Our study also has several limitations. We acknow-
ledge that the final recruitment results in SHARE are
not a perfect gold standard because they are affected by
some external factors rather than clinical information
alone such as personal preferences. The algorithm might
have correctly identified an eligible participant but this
person had not been enrolled in the study due to per-
sonal reasons, although our evaluation results would
only be underestimated in this case. Whilst acknowledg-
ing this inherent lack of knowledge as a limitation of the
study, we believe that we have demonstrated results in
agreement with Miotto & Weng’s key finding that by
matching EHR data of unseen patients to a target de-
rived by case-based reasoning, we can estimate relevance
to a forthcoming trial, with higher relevance being asso-
ciated with higher eligibility. Additionally, the clinical
data used for this study do not consist of free-text clin-
ical notes, possibly impacting on performance; a final
limitation is that despite our careful checking of final re-
cruitment status for each project, the recruitment data
may contain some misclassifications.
Conclusions
In this study we have demonstrated that case-based
reasoning performed well in predicting recruitment for
population-based clinical studies using Scottish EHR
data. Our results were substantially worse than those
reported by Miotto & Weng [7] with regard to ranking
lists derived from the similarity scores from case-based
reasoning analysis. Our results suggest that the
provision of more accurate recruitment data and more
abundant clinical data resources (including narrative
clinical notes) would improve our ability to derive ac-
curate ranking lists, with no negative impact on clinical
care for the population (consistent with the primary
purpose of EHRs). Planned prospective studies compar-
ing the actual recruitment results for persons identified
by differed methods should help address the question
of which ones are most suitable for finding potential
participants. Our analytical framework could usefully
enhance the existing database query method in
Scotland, and form the basis of participant prediction
schemes in other healthcare settings.
Table 2 Performance of the resulted ranking lists. For each
project we give the number of participants appearing in the
top 5 and top 10 of a ranking list, the mean average precision
(MAP) and the mean reciprocal rank (MRR)
List P5 P10 MAP MRR
ALPHA 0 0 0.003 0.006
ALLAY 0 0 0.001 0.001
METFORMIN 0 0 0.003 0.002
REFORM 0 0 0.010 0.035
IMPOCT 0 0 0.000 0.000
TARDIS 0 0 0.002 0.005
4P 0 0 0.002 0.003
HF 0 0 0.006 0.028
ImmunoStat 0 0 0.001 0.007
Average of all ranking lists 0 0 0.003 0.010
Averaged Lower 0 0 0.000 0.000
Averaged Upper 0.789 0.611 1 1
Table 3 Proportion of persons both identified within the top 50
positions of the ranking list for each project
Project acronym Fold 1 Fold 2 Average
ALPHA 0.66 0.32 0.49
ALLAY 0.54 0.54 0.54
METFORMIN 0 0 0.00
REFORM 0.32 0.16 0.24
IMPOCT 0 0 0.00
TARDIS 0.22 0 0.11
4P 0.06 0.14 0.10
HF 0.30 0.42 0.36
ImmunoStat 0.04 0.08 0.06
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